Brass Tax Wealth Management Inc. Takes Position in Axon Enterprise, Inc. (NASDAQ:AXON)

Brass Tax Wealth Management Inc. acquired a new stake in shares of Axon Enterprise, Inc. (NASDAQ:AXON) in the third quarter, Holdings Channel.com reports. The firm acquired 600 shares of the biotechnology company’s stock, valued at approximately $240,000.

Other large investors have also made changes to their positions in the company. Blue Trust Inc. raised its position in Axon Enterprise by 987.5% in the second quarter. Blue Trust Inc. now owns 87 shares of the biotechnology company’s stock worth $27,000 after purchasing an additional 79 shares in the last quarter. Quent Capital LLC raised its position in Axon Enterprise by 1,875.0% in the third quarter. Quent Capital LLC now owns 79 shares of the biotechnology company’s stock worth $32,000 after purchasing an additional 75 shares in the last quarter. Prestige Wealth Management Group LLC raised its position in Axon Enterprise by 115.8% in the third quarter. Prestige Wealth Management Group LLC now owns 82 shares of the biotechnology company’s stock worth $33,000 after purchasing an additional 44 shares in the last quarter. Brooklyn Investment Group bought a new stake in Axon Enterprise during the third quarter worth about $41,000. Finally, Asset Dedication LLC bought a new stake in Axon Enterprise during the second quarter worth about $47,000. Institutional investors and hedge funds own 79.08% of the company’s stock.

Insiders Place Their Bets

In other Axon Enterprise news, CEO Patrick W. Smith sold 47,314 shares of the stock in a transaction on Tuesday, October 1st. The shares were sold at an average price of $400.07, for a total value of $18,928,911.98. Following the sale, the chief executive officer now directly owns 2,983,802 shares in the company, valued at approximately $1,193,729,666.14. This trade represents a 1.56 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director Julie A. Cullivan sold 1,261 shares of the stock in a transaction on Wednesday, December 4th. The stock was sold at an average price of $682.06, for a total transaction of $860,077.66. Following the completion of the sale, the director now owns 2,392 shares in the company, valued at approximately $1,631,487.52. This trade represents a 34.52 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 99,590 shares of company stock worth $49,176,907. Company insiders own 6.10% of the company’s stock.

Axon Enterprise Trading Up 0.4 %

AXON stock traded up $2.54 during midday trading on Friday, reaching $638.95. The company’s stock had a trading volume of 133,072 shares, compared to its average volume of 570,881. Axon Enterprise, Inc. has a 52 week low of $241.72 and a 52 week high of $698.67. The stock has a market cap of $48.72 billion, a PE ratio of 164.45, a price-to-earnings-growth ratio of 14.14 and a beta of 1.01. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32. The business’s 50-day simple moving average is $535.05 and its 200-day simple moving average is $402.14.

Analyst Upgrades and Downgrades

Several analysts have weighed in on the stock. Needham & Company LLC upped their price objective on shares of Axon Enterprise from $525.00 to $600.00 and gave the stock a “buy” rating in a research note on Friday, November 8th. JMP Securities upped their price objective on shares of Axon Enterprise from $430.00 to $500.00 and gave the stock a “market outperform” rating in a research note on Thursday, October 31st. The Goldman Sachs Group upped their price objective on shares of Axon Enterprise from $385.00 to $441.00 and gave the stock a “buy” rating in a research note on Wednesday, October 23rd. Robert W. Baird upped their price objective on shares of Axon Enterprise from $600.00 to $800.00 and gave the stock an “outperform” rating in a research note on Friday, December 6th. Finally, Morgan Stanley raised shares of Axon Enterprise from an “equal weight” rating to an “overweight” rating and increased their price target for the company from $500.00 to $700.00 in a research note on Tuesday, December 3rd. One analyst has rated the stock with a hold rating and thirteen have issued a buy rating to the company’s stock. According to MarketBeat, Axon Enterprise presently has a consensus rating of “Moderate Buy” and an average target price of $488.67.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.